Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...